Medpace Holdings, Inc. Repayments of Debt
Medpace Holdings, Inc. (MEDP) reported Repayments of Debt of $0 for the 12-month period ending 2021-12-31, per its 10-K filed 2022-02-15.
Discontinued › Cash Flow › Financing Activities
us-gaap:RepaymentsOfDebt · last filed 2022-02-15
- Medpace Holdings, Inc. repayments of debt for the quarter ending 2020-12-31 was $0.00.
- Medpace Holdings, Inc. repayments of debt for the quarter ending 2020-09-30 was $0.00.
- Medpace Holdings, Inc. repayments of debt for the quarter ending 2020-06-30 was $0.00, a 100.00% decline year-over-year.
- Medpace Holdings, Inc. repayments of debt for the quarter ending 2020-03-31 was $0.00, a 100.00% decline year-over-year.
- Medpace Holdings, Inc. repayments of debt for fiscal 2021 was $0.00.
- Medpace Holdings, Inc. repayments of debt for fiscal 2020 was $0.00, a 100.00% decline from fiscal 2019.
- Medpace Holdings, Inc. repayments of debt for fiscal 2019 was $80.44M, a 11.43% increase from fiscal 2018.
- Medpace Holdings, Inc. repayments of debt for fiscal 2018 was $72.19M, a 483.34% increase from fiscal 2017.
| Period end | Repayments of Debt 3 month | Repayments of Debt 6 month | Repayments of Debt 9 month | Repayments of Debt 12 month |
|---|---|---|---|---|
| 2021-12-31 | $0.00 10-K · filed 2022-02-15 | |||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-15 | $0.00 derived: sum of 2 quarters · filed 2022-02-15 | $0.00 derived: sum of 3 quarters · filed 2022-02-15 | $0.00 10-K · filed 2022-02-15 |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-27 | $0.00 derived: sum of 2 quarters · filed 2020-10-27 | $0.00 10-Q · filed 2020-10-27 | $0.00 derived: sum of 4 quarters · filed 2022-02-15 |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-28 | $0.00 10-Q · filed 2020-07-28 | $0.00 derived: sum of 3 quarters · filed 2022-02-15 | $0.00 derived: sum of 4 quarters · filed 2022-02-15 |
| 2020-03-31 | $0.00 10-Q · filed 2020-04-29 | $0.00 derived: sum of 2 quarters · filed 2022-02-15 | $0.00 derived: sum of 3 quarters · filed 2022-02-15 | $56.44M derived: sum of 4 quarters · filed 2022-02-15 |
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-15 | $0.00 derived: sum of 2 quarters · filed 2022-02-15 | $56.44M derived: sum of 3 quarters · filed 2022-02-15 | $80.44M 10-K · filed 2022-02-15 |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-27 | $56.44M derived: sum of 2 quarters · filed 2020-10-27 | $80.44M 10-Q · filed 2020-10-27 | $114.47M derived: sum of 4 quarters · filed 2021-02-16 |
| 2019-06-30 | $56.44M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-28 | $80.44M 10-Q · filed 2020-07-28 | $114.47M derived: sum of 3 quarters · filed 2021-02-16 | $144.38M derived: sum of 4 quarters · filed 2021-02-16 |
| 2019-03-31 | $24.00M 10-Q · filed 2020-04-29 | $58.03M derived: sum of 2 quarters · filed 2021-02-16 | $87.94M derived: sum of 3 quarters · filed 2021-02-16 | $92.06M derived: sum of 4 quarters · filed 2021-02-16 |
| 2018-12-31 | $34.03M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-16 | $63.94M derived: sum of 2 quarters · filed 2021-02-16 | $68.06M derived: sum of 3 quarters · filed 2021-02-16 | $72.19M 10-K · filed 2021-02-16 |
| 2018-09-30 | $29.91M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-29 | $34.03M derived: sum of 2 quarters · filed 2019-10-29 | $38.16M 10-Q · filed 2019-10-29 | $41.25M derived: sum of 4 quarters · filed 2020-02-25 |
| 2018-06-30 | $4.13M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-30 | $8.25M 10-Q · filed 2019-07-30 | $11.34M derived: sum of 3 quarters · filed 2020-02-25 | $14.44M derived: sum of 4 quarters · filed 2020-02-25 |
| 2018-03-31 | $4.13M 10-Q · filed 2019-04-30 | $7.22M derived: sum of 2 quarters · filed 2020-02-25 | $10.31M derived: sum of 3 quarters · filed 2020-02-25 | $13.41M derived: sum of 4 quarters · filed 2020-02-25 |
| 2017-12-31 | $3.09M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | $6.19M derived: sum of 2 quarters · filed 2020-02-25 | $9.28M derived: sum of 3 quarters · filed 2020-02-25 | $12.38M 10-K · filed 2020-02-25 |
| 2017-09-30 | $3.09M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-30 | $6.19M derived: sum of 2 quarters · filed 2018-10-30 | $9.28M 10-Q · filed 2018-10-30 | $174.29M derived: sum of 4 quarters · filed 2019-02-26 |
| 2017-06-30 | $3.09M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-31 | $6.19M 10-Q · filed 2018-07-31 | $171.19M derived: sum of 3 quarters · filed 2019-02-26 | $381.21M derived: sum of 4 quarters · filed 2019-02-26 |
| 2017-03-31 | $3.09M 10-Q · filed 2018-05-01 | $168.10M derived: sum of 2 quarters · filed 2019-02-26 | $378.12M derived: sum of 3 quarters · filed 2019-02-26 | $393.14M derived: sum of 4 quarters · filed 2019-02-26 |
| 2016-12-31 | $165.01M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | $375.02M derived: sum of 2 quarters · filed 2019-02-26 | $390.04M derived: sum of 3 quarters · filed 2019-02-26 | $390.06M 10-K · filed 2019-02-26 |
| 2016-09-30 | $210.02M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-31 | $225.04M derived: sum of 2 quarters · filed 2017-10-31 | $225.05M 10-Q · filed 2017-10-31 | $275.07M derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-06-30 | $15.02M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-01 | $15.04M 10-Q · filed 2017-08-01 | $65.05M derived: sum of 3 quarters · filed 2018-02-27 | |
| 2016-03-31 | $18.00K 10-Q · filed 2017-05-02 | $50.04M derived: sum of 2 quarters · filed 2018-02-27 | ||
| 2015-12-31 | $50.02M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $116.06M 10-K · filed 2018-02-27 | ||
| 2015-09-30 | $66.04M 10-Q · filed 2016-11-03 | |||
| 2014-12-31 | $25.22M 10-K · filed 2017-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |